NCT07716540 Analgesic Efficacy of Ultrasound-Guided Deep Iliacus Plane Block in Patients Undergoing Hip Fracture Surgery
| NCT ID | NCT07716540 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kanuni Sultan Suleyman Training and Research Hospital |
| Condition | Pain Management |
| Study Type | INTERVENTIONAL |
| Enrollment | 52 participants |
| Start Date | 2026-07-20 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 52 participants in total. It began in 2026-07-20 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Hip fracture surgery is commonly associated with moderate to severe postoperative pain, which may delay mobilization and increase the need for opioid analgesics. The deep iliacus plane block is a recently described ultrasound-guided regional anesthesia technique designed to provide analgesia by allowing local anesthetic spread toward the femoral nerve, lateral femoral cutaneous nerve, and articular branches supplying the hip. This prospective, randomized, double-blind, sham-controlled clinical trial will evaluate the analgesic efficacy of the deep iliacus plane block in adult patients undergoing hip fracture surgery under spinal anesthesia. After surgery, participants will be randomly assigned to receive either an ultrasound-guided deep iliacus plane block with local anesthetic or a sham block with normal saline. All participants will receive standardized multimodal postoperative analgesia, including patient-controlled analgesia. The primary objective is to determine whether the deep iliacus plane block reduces postoperative opioid consumption during the first 24 hours after surgery. Postoperative pain scores, rescue analgesic requirements, sensory distribution, motor block, nausea and vomiting, quality of recovery, patient satisfaction, and block-related complications will also be evaluated.
Eligibility Criteria
Inclusion Criteria: * Age 18 years or older * Scheduled to undergo unilateral hip fracture surgery under spinal anesthesia * American Society of Anesthesiologists (ASA) physical status I-III * Ability to understand and use the Numerical Rating Scale and patient-controlled analgesia device * No contraindication to spinal anesthesia or the deep iliacus plane block * Written informed consent provided by the participant or legally authorized representative Exclusion Criteria: * ASA physical status IV or higher * Emergency surgery * Coagulopathy, bleeding diathesis, or anticoagulant treatment that contraindicates spinal anesthesia or peripheral nerve block * Infection at the planned needle insertion site * Known allergy to local anesthetics or any study medication * Pre-existing peripheral neuropathy, neurological disorder, or motor deficit involving the operated lower extremity * Inability to understand or use the Numerical Rating Scale or patient-controlled analgesia device * Cognitive impairment or communication difficulty preventing reliable postoperative assessment * Refusal to participate
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07716540 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pain Management. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07716540 currently recruiting?
Yes, NCT07716540 is actively recruiting participants. Contact the research team at enginihsan@hotmail.com for enrollment information.
Where is the NCT07716540 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07716540 clinical trial?
NCT07716540 is sponsored by Kanuni Sultan Suleyman Training and Research Hospital. The trial plans to enroll 52 participants.